Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

35.340
-1.380-3.76%
Volume:18.34M
Turnover:648.44M
Market Cap:214.30B
PE:32.57
High:36.620
Open:36.060
Low:35.000
Close:36.720
52wk High:43.939
52wk Low:27.882
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.06
T/O Rate:0.30%
Dividend:0.49
Dividend Rate:1.40%
EPS(LYR):1.085
ROE:19.40%
ROA:9.08%
PB:4.86
PE(LYR):32.57
PS:11.55

Loading ...

Hansoh Pharmaceutical Group Stock Climbs 4.9% in Hong Kong

Dow Jones
·
Aug 10

Movement Alert|HANSOH PHARMA Rises 3.65% in Regular Trading, New Drug Clinical Approval and Pipeline Milestones Drive Momentum

Market Focus
·
Aug 10

Hansoh Pharmaceutical Group Stock Rises 3.9% in Hong Kong

Dow Jones
·
Aug 07

Movement Alert|HANSOH PHARMA Rises 3.6% in Regular Trading, New Drug HS-10582 Receives NMPA Clinical Trial Approval

Market Focus
·
Aug 07

Hansoh Pharma Receives NMPA Clearance for HS-10582 Phase I Clinical Trials in Hypercholesterolemia

Bulletin Express
·
Aug 06

HANSOH PHARMA Receives Clinical Trial Approval for HS-10582 Tablets

Stock News
·
Aug 06

Hansoh Pharmaceutical - Clinical Trial Approval for Hs-10582 Tablets Issued By- National Medical Products Administration

THOMSON REUTERS
·
Aug 06

Hansoh Pharma Sets 26 Aug 2026 Board Meeting to Review 1H26 Results and Interim Dividend

Bulletin Express
·
Aug 04

HANSOH PHARMA July 2026 Share Capital Update: No Change in Issued Shares; HKD 4.68 Billion Convertibles Outstanding

Bulletin Express
·
Aug 04

Hansoh Pharmaceutical Group Stock Slides 2.1% in Hong Kong

Dow Jones
·
Aug 03

Movement Alert|HANSOH PHARMA Declines 3.05% in Regular Trading, Trading at 31.16 HKD

Market Focus
·
Aug 03

Movement Alert|HANSOH PHARMA Falls 3.04% in Regular Trading, Pharmaceutical Sector Broadly Under Pressure

Market Focus
·
Jul 30

Hansoh Pharmaceutical Group Stock Rallies 3.7% in Hong Kong

Dow Jones
·
Jul 29

Offshore Wind Tendering Heats Up in July as ASMPT Posts Strong Interim Profit Jump

Stock News
·
Jul 29

GSK Q2 Sales Beat Analyst Estimates on Specialty Medicines Growth

Reuters
·
Jul 28

GSK, Hansoh's Cancer Drug Meets Main Goal of Bone Cancer Trial

Reuters
·
Jul 28

Hansoh Pharma's HS-20093 Achieves Primary Goal in Phase III Osteosarcoma Study

Stock News
·
Jul 28

Hansoh Pharma Says Artemis-011 Phase 3 Trial of Hs-20093 Meets Primary PFS Endpoint in Osteosarcoma

Reuters
·
Jul 28

Hansoh Pharmaceutical - to Initiate Biologics License Application Process in China in the Near Term

THOMSON REUTERS
·
Jul 28

Hansoh Pharmaceutical - Phase Iii Clinical Study of Hs-20093 in Treatment- of Osteosarcoma Has Met Primary Endpoint

THOMSON REUTERS
·
Jul 28